Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 1863 entries
View as:

Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002783 Org: User:
Start: 05/31/96 End: 01/31/01 Due: 01/31/02

A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00745381 Org: User:
Start: 08/31/08 End: 07/30/20 Due: 07/30/21

Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT00590954 Org: User:
Start: 05/31/06 End: 11/11/19 Due: 11/11/20

Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00004066 Org: User:
Start: 06/30/99 End: 10/31/03 Due: 10/31/04

Patient-Controlled Epidural Analgesia (PCEA) for Patients Who Have Had Major Open Gynecologic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00136682 Org: User:
Start: 08/31/04 End: 07/31/07 Due: 07/31/08

Assess the Variability of Uni-Dimensional, Bi-Dimensional, and Volumetric CT Scan Measurement of Non-Small Cell Lung Cancer Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00579852 Org: User:
Start: 11/30/06 End: 01/31/08 Due: 01/31/09

10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004238 Org: User:
Start: 07/31/99 End: 06/30/02 Due: 06/30/03

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT00030823 Org: User:
Start: 03/31/01 End: 02/28/09 Due: 02/28/10

A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT02278003 Org: User:
Start: 02/29/12 End: 05/10/17 Due: 05/10/18

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01938729 Org: User:
Start: 09/05/13 End: 09/10/20 Due: 09/10/21

PEACE: Comparing Chronic Pain Treatment Options

Phase: N/A Priority: Normal
NCT ID: NCT02979574 Org: User:
Start: 11/30/16 End: 11/30/25 Due: 11/30/26

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04459416 Org: User:
Start: 06/30/20 End: 06/30/25 Due: 06/30/26

T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT03531736 Org: User:
Start: 05/09/18 End: 05/31/25 Due: 05/31/26

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Phase: N/A Priority: Normal
NCT ID: NCT03107416 Org: User:
Start: 04/05/17 End: 04/05/26 Due: 04/05/27

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002766 Org: User:
Start: 03/31/96 End: 09/30/11 Due: 09/30/12

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06448208 Org: User:
Start: 06/03/24 End: 06/30/26 Due: 06/30/27

A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06394804 Org: User:
Start: 04/29/24 End: 04/30/27 Due: 04/30/28

Study of Poetic Dignity Therapy for Sexual and Gender Minority Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06293456 Org: User:
Start: 01/29/24 End: 01/31/26 Due: 01/31/27

A Study Comparing Mindfulness Apps to Decrease Anxiety in People With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06008574 Org: User:
Start: 08/11/23 End: 08/31/25 Due: 08/31/26

Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00713219 Org: User:
Start: 07/31/08 End: 04/30/13 Due: 04/30/14

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06915116 Org: User:
Start: 03/31/25 End: 03/31/27 Due: 03/31/28

A Study of Changes in Heart Function and Blood Flow in People Receiving Anesthesia

Phase: N/A Priority: Normal
NCT ID: NCT05954832 Org: User:
Start: 07/13/23 End: 07/31/27 Due: 07/31/28

Empathic Communication Skills (ECS) Training

Phase: N/A Priority: Normal
NCT ID: NCT05456841 Org: User:
Start: 04/28/23 End: 08/31/26 Due: 08/31/27

Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin

Phase: N/A Priority: Normal
NCT ID: NCT00002559 Org: User:
Start: 01/31/94 End: 01/31/03 Due: 01/31/04

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00005791 Org: User:
Start: 10/31/99 End: 12/31/09 Due: 12/31/10